+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

DNA Synthesizer Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 350 Pages
  • July 2025
  • Region: Global
  • Expert Market Research
  • ID: 6163037
The global DNA synthesizer market size was valued at USD 261.06 Million in 2024, driven by the increasing demand for efficient DNA synthesizers across the globe. The market size is anticipated to grow at a CAGR of 14.40% during the forecast period of 2025-2034 to achieve a value of USD 1.00 billion by 2034.

DNA Synthesizer: Introduction

DNA synthesizers are devices that produce DNA molecules with a specific sequence of nucleotides. These molecules can be utilized to treat diseases by replacing damaged DNA with repaired sections. A DNA synthesizer is a crucial laboratory instrument used to chemically create or synthesize DNA molecules. It plays a vital role in molecular biology, genetics, and biotechnology research, as it enables scientists to design custom DNA sequences for different purposes, including cloning, gene expression studies, genetic engineering, and DNA sequencing.

Global DNA Synthesizer Market Analysis

The increasing demand for DNA synthesis technology is due to the widespread application in research to better understand the mechanisms of disease and in the drug discovery process to combat disease is a major trend influencing the market growth.

The continuous research and development activities by biotech firms and other institutions are also majorly contributing to the global DNA synthesizer market growth. For example, recently this year, Ansa Biotechnologies, Inc. claimed a successful creation of the world's longest DNA oligonucleotide in a single synthesis. The 1005-base sequence codes for a key part of an adeno-associated virus vector used to develop gene therapy.

The market is experiencing heavy investments by synthetic biology companies that are interested in developing new technological advancements in this area, further expected to expand the market growth. For example, a UK-based synthetic biology company, Camena Bioscience, recently announced the closing of a USD 10 million Series A financing round, led by Mercia, a UK-based venture capital firm. Camena aims to scale operations and continue developing gSynth, its enzyme-based DNA synthesis platform.

Global DNA Synthesizer Market Segmentations

DNA Synthesizer Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

  • Benchtop DNA Synthesizers
  • Large-scale DNA Synthesizers

Market Breakup by Application

  • Research and Development
  • Academic
  • Industrial
  • Diagnosis
  • Therapeutics

Market Breakup by End User

  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global DNA Synthesizer Market Overview

The growth of the market is expected to be driven by the increasing demand for efficient DNA synthesizers from life science laboratories and pharmaceutical and biotechnology companies. Another key factor is the rapid developments in genomics and life sciences, boosting the market growth further. The increasing significance of DNA synthesizers in synthetic and molecular biology is also supporting the market growth. The market is also experiencing high demand for nucleic acid synthesis platforms among several end users, further propelling the global DNA synthesizer market growth.

The increasing technological advancements are also a key factor driving the global market. The proven efficacy of benchtop DNA synthesizers as they increase the speed and efficiency of research in academic and industrial labs is contributing to the increased demand in the market, further expected to boost the growth of the market in the coming years.

The efforts to lower the cost of synthesizing DNA oligonucleotides and commercialize scalable DNA synthesizers are continuously increasing. Significant progress has been made towards the goal of affordable DNA synthesis with microfluidic/microarray oligonucleotide synthesis methods and improvements in synthetic DNA quality.

Furthermore, ongoing advancements in other efficient synthesis technologies are also expected to make synthesizers widely available at lower costs, adding further value to the global DNA synthesizer market share.

North America is currently leading the global market and is expected to keep leading throughout the forecast period due to the presence of several key players in the market and their continuous developments. Moreover, the market is also driven by ongoing technological advancements, increased investment in research and development activities, and growing demand for innovative synthesizers.

Global DNA Synthesizer Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • LGC Biosearch Technologies
  • Bioneer Corporation
  • Thermo Fisher Scientific, Inc.
  • IBA GmbH
  • Twist Bioscience
  • Eton Bioscience
  • Quintara Biosciences
  • Eurofins Scientific
  • Integrated DNA Technologies, Inc
  • Integrated DxNA Technologies, Inc

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global DNA Synthesizer Market Overview
3.1 Global DNA Synthesizer Market Historical Value (2018-2024)
3.2 Global DNA Synthesizer Market Forecast Value (2025-2034)
4 Global DNA Synthesizer Market Landscape
4.1 DNA Synthesizer: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 DNA Synthesizer: Product Landscape
4.2.1 Analysis by Application
4.2.2 Analysis by Type
4.2.3 Analysis by End User
5 Global DNA Synthesizer Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global DNA Synthesizer Market Segmentation
6.1 Global DNA Synthesizer Market by Type
6.1.1 Market Overview
6.1.2 Benchtop DNA Synthesizers
6.1.3 Large-scale DNA Synthesizers
6.2 Global DNA Synthesizer Market by Application
6.2.1 Market Overview
6.2.2 Research and Development
6.2.3 Academic
6.2.4 Industrial
6.2.5 Diagnosis
6.2.6 Therapeutics
6.3 Global DNA Synthesizer Market by End User
6.3.1 Market Overview
6.3.2 Biopharmaceutical Companies
6.3.3 Academic and Research Institutes
6.3.4 Contract Research Organizations
6.4 Global DNA Synthesizer Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America DNA Synthesizer Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe DNA Synthesizer Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific DNA Synthesizer Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America DNA Synthesizer Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa DNA Synthesizer Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 LGC Biosearch Technologies
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Bioneer Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Thermo Fisher Scientific, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 IBA GmbH
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Twist Bioscience
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Eton Bioscience
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Quintara Biosciences
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Eurofins Scientific
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Integrated DNA Technologies, Inc
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Integrated DxNA Technologies, Inc
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket

Companies Mentioned

  • LGC Biosearch Technologies
  • Bioneer Corporation
  • Thermo Fisher Scientific, Inc.
  • IBA GmbH
  • Twist Bioscience
  • Eton Bioscience
  • Quintara Biosciences
  • Eurofins Scientific
  • Integrated DNA Technologies, Inc
  • Integrated DxNA Technologies, Inc